Talk:Lamotrigine: Difference between revisions
m Archiving 1 discussion(s) to Talk:Lamotrigine/Archive 2) (bot |
m Archiving 1 discussion(s) to Talk:Lamotrigine/Archive 2) (bot |
||
(11 intermediate revisions by 10 users not shown) | |||
Line 1: | Line 1: | ||
{{Reliable sources for medical articles}} |
{{Reliable sources for medical articles}} |
||
{{talk header}} |
{{talk header}} |
||
{{WikiProject banner shell|class=B| |
|||
{{WikiProjectBannerShell|1= |
|||
{{WikiProject Medicine |
{{WikiProject Medicine |importance=mid}} |
||
{{WikiProject Pharmacology |
{{WikiProject Pharmacology |importance=high}} |
||
}} |
|||
{{User:MiszaBot/config |
{{User:MiszaBot/config |
||
|archiveheader = {{atnhead|noredlinks=y}} |
|archiveheader = {{atnhead|noredlinks=y}} |
||
|maxarchivesize = 40K |
|maxarchivesize = 40K |
||
|counter = 2 |
|counter = 2 |
||
|minthreadsleft = |
|minthreadsleft = 2 |
||
|minthreadstoarchive = 0 |
|minthreadstoarchive = 0 |
||
|algo = old( |
|algo = old(180d) |
||
|archive = Talk:Lamotrigine/Archive %(counter)d |
|archive = Talk:Lamotrigine/Archive %(counter)d |
||
}} |
}} |
||
== Sleep disturb % is misstated. == |
|||
Not, "However, a retrospective study of 109 patients' medical records found that 6.7% of patients experienced an "alerting effect" resulting in intolerable insomnia, for which the treatment had to be discontinued. (65)" |
|||
It's only 6.4%. |
|||
65) Sadler M (March 1999). "Lamotrigine associated with insomnia". Epilepsia. 40 (3): 322–5. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. S2CID 43902298. [[Special:Contributions/98.144.238.191|98.144.238.191]] ([[User talk:98.144.238.191|talk]]) 17:28, 29 June 2022 (UTC) |
|||
How to take this medication. Empty stomach? With food? Time of day? Etc. [[Special:Contributions/68.66.100.253|68.66.100.253]] ([[User talk:68.66.100.253|talk]]) 14:36, 8 January 2024 (UTC) |
|||
== Receptor activity listed in article not found in cited source == |
|||
Receptor activity is listed as antagonistic at 5-HT3 and σ receptors with IC50 of 18 μM and 145 μM, respectively. The inline citation is [5] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678. Neither the live webpage cited nor the archived version make any mention of antagonistic activity at 5-HT3 or σ receptors unless I'm mistaken. Moreover, the ligands section of the [[sigma receptor]] page lists Lamotrigine as an *agonist* of the σ receptors with two inline citations, one of which I can't access and the other of which makes no mention of activity at σ receptors at all. [[User:UriNation69420|UriNation69420]] ([[User talk:UriNation69420|talk]]) 17:21, 26 June 2024 (UTC) |
Latest revision as of 14:11, 27 June 2024
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lamotrigine.
|
This is the talk page for discussing improvements to the Lamotrigine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2Auto-archiving period: 6 months |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Sleep disturb % is misstated.
[edit]Not, "However, a retrospective study of 109 patients' medical records found that 6.7% of patients experienced an "alerting effect" resulting in intolerable insomnia, for which the treatment had to be discontinued. (65)"
It's only 6.4%.
65) Sadler M (March 1999). "Lamotrigine associated with insomnia". Epilepsia. 40 (3): 322–5. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. S2CID 43902298. 98.144.238.191 (talk) 17:28, 29 June 2022 (UTC)
How to take this medication. Empty stomach? With food? Time of day? Etc. 68.66.100.253 (talk) 14:36, 8 January 2024 (UTC)
Receptor activity listed in article not found in cited source
[edit]Receptor activity is listed as antagonistic at 5-HT3 and σ receptors with IC50 of 18 μM and 145 μM, respectively. The inline citation is [5] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678. Neither the live webpage cited nor the archived version make any mention of antagonistic activity at 5-HT3 or σ receptors unless I'm mistaken. Moreover, the ligands section of the sigma receptor page lists Lamotrigine as an *agonist* of the σ receptors with two inline citations, one of which I can't access and the other of which makes no mention of activity at σ receptors at all. UriNation69420 (talk) 17:21, 26 June 2024 (UTC)